16-Aug-2022 | Facts and Factors
According to Facts and Factors, the global cell and gene therapy consumables market size was worth USD 6,294.10 million in 2021 and is estimated to grow to USD 17,427.85 million by 2028, with a compound annual growth rate (CAGR) of approximately 18.50% over the forecast period. The report analyzes the cell and gene therapy consumables market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the cell and gene therapy consumables market.
Cell and gene therapy (CGT) is a quickly developing discipline developing potential new treatments for genetic and cancerous disorders and moving into autoimmune, cardiovascular, musculoskeletal, and many other ailments. Researchers, patient organizations, and regulators have shown great interest and hope in the cell and gene therapy sector, which has resulted in significant R&D investment. Numerous governments and regulatory agencies have developed policies and patent settings to promote cell and gene therapy growth. There is a sense of urgency in the pharma/biofield to create cell and gene therapies because they frequently target areas of uncommon and underserved diseases for which there are few other treatments available. The number of cell and gene therapy products being reviewed in the early stages of development has increased, according to the U.S. Food and Drug Administration (FDA). The increased number of investigational new drug (IND) applications can serve as additional proof. Several medication developers prefer to rely on third-party service providers to deliver raw materials, such as cell culture medium, cell isolation kits, and cell separation reagents, to generate high-quality cellular and gene treatments. Over 60 service providers supply raw materials and consumables to develop cell and gene therapies.
Browse the full “Cell and Gene Therapy Consumables Market Size, Share, Growth Analysis Report By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Others), By Fleet Type (Commercial Fleet, Non-Commercial Fleet ), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/cell-and-gene-therapy-consumables-market
The market will grow during the period as knowledge of gene and cell therapies increases. However, randomized control tests will prevent the market from growing throughout the predicted time frame. However, the rising popularity of using cell and gene therapy to treat neurodegenerative diseases will fuel market expansion in the upcoming years. Due to the rising prevalence of chronic illnesses like cancer and heart conditions, the market is expected to grow during forecasting. In addition, an increase in the prevalence of these conditions generates a profitable market need for improved therapeutics, which will peak throughout the projection period. The market is expanding due to the rise in the prevalence of genetic illnesses like cystic fibrosis and sickle cell anemia, as well as the increase in funding for research and development of cell and gene therapies. The strategic moves made by market participants and the increase in spending in the healthcare sector are two additional variables projected to fuel the expansion of the global cell and gene therapy consumables market. It supports the expansion of the cell and gene therapy consumables market.
Segmental Overview
The global cell and gene therapy consumables market is segregated based on deployment, component, fleet type, and region. Based on product, the market is segregated into cell and gene therapy. In 2021, the gene therapy segment dominated the global cell and gene therapy consumables. Based on the application, the market is segregated into oncology, dermatology, musculoskeletal and others. In 2021, the dermatology category dominated the global cell and gene therapy consumables. Based on the end-user, the market is segmented into hospitals, ambulatory surgical centers, cancer care centers, wound care centers and others. In 2021, the hospital's segment dominated the global cell and gene therapy consumables.
Regional Overview
The global cell and gene therapy consumables market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominated the global market for cell and gene therapy consumables in 2021. due to the widespread presence of genetic diseases. In the U.S., 135 million new cases of Parkinson's disease and traumatic brain injuries are reported yearly. Around 1.2 million adults are diagnosed with early symptoms of brain illnesses each year, of which Alzheimer's disease causes 21%. The need for cell and gene therapy is also anticipated to rise with increased research and development activity. The expansion of cell and gene therapy consumables in the U.S. is being driven by the regulatory approval process, which is developing and becoming more beneficial for vendors creating goods for cell and gene therapy.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 6,294.10 Million |
Projected Market Size in 2028 |
USD 17,427.85 Million |
CAGR Growth Rate |
18.50% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Novartis AG, Amgen, Merck, Gilead Sciences, Bristol-Myers Squibb, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, Fibrocell Science, and Others |
Key Segment |
By Product, Application, Fleet Type, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key Players Insights
The report contains qualitative and quantitative research on the global cell and gene therapy consumables market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness.
Key players in the global cell and gene therapy consumables market include Novartis AG, Amgen, Merck, Gilead Sciences, Bristol-Myers Squibb, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio, and Fibrocell Science.
Global Cell and Gene Therapy Consumables Market are segmented as follows:
By Product
- Cell Therapy
- Gene Therapy
By Application
- Oncology
- Dermatology
- Musculoskeletal
- Others
By Fleet Type
- Commercial Fleet
- Non-Commercial Fleet
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
